145 filings
Page 4 of 8
8-K
ma4052wtpq8p
12 Aug 19
Phio Pharmaceuticals Reports Second Quarter 2019
5:10pm
8-K
glqsw
9 Aug 19
Entry into a Material Definitive Agreement
5:20pm
8-K
om0nh3s31k7dd7ze 7x
14 May 19
Phio Pharmaceuticals Reports First Quarter 2019
5:20pm
8-K
dxsh773rp8h tx5llem
27 Mar 19
Phio Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Corporate Highlights
5:16pm
8-K
mabapd4kfspd99updep
15 Feb 19
Phio Pharmaceuticals Appoints Gerrit Dispersyn as New Chief Executive Officer Effective March 1
5:00pm
8-K
y8mc200ir42g
28 Jan 19
Entry into a Material Definitive Agreement
5:15pm
8-K
i7zo869vc1we
21 Dec 18
Departure of Directors or Certain Officers
7:05am
8-K
m7ks vtjme
19 Nov 18
Departure of Directors or Certain Officers
12:00am
8-K
namwhagau9pki7 gw
14 Nov 18
RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
7:10am
8-K
g0o3ql
13 Nov 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:20pm
8-K
cnjvvd2b9wblaw 4p
5 Oct 18
RXI PHARMACEUTICALS Announces Pricing of $15 Million UPSIZED UNDERWRITTEN Public Offering
5:00pm
8-K
l7aj61b5r93 093tb
26 Sep 18
Regulation FD Disclosure
8:00am
8-K
1me2dtk7w
4 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
tjh2bybn2zx2a0v8y4
21 Aug 18
Other Events
12:00am
8-K
su3c9ogak4p4
14 Aug 18
RXi Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
9:15am
8-K
l9x3 3c7qa
8 Jun 18
Submission of Matters to a Vote of Security Holders
5:02pm
8-K
ysh45llhzf4l bflrei
1 Jun 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
y6azc88
10 May 18
Results of Operations and Financial Condition
7:16am
8-K
76knvrfnjch 76w
11 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
o8trezs711skgztv dt1
29 Mar 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am